Mesa Laboratories Inc. | Small-cap | Technology
$63.76
-1.53%
| Mesa Laboratories Stock Comparison:
Mesa Laboratories vs GarminMesa Laboratories vs KeysightMesa Laboratories vs Faro TechnologiesMesa Laboratories vs Ituran Location andMesa Laboratories vs Vishay PrecisionMesa Laboratories vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 59.5M
Gross Profit 36.9M 62.04%
Operating Income 3.1M 5.15%
Net Income 4.7M 7.96%
EPS (Diluted) $0.85

Balance Sheet Metrics

Total Assets 433.3M
Total Liabilities 273.5M
Shareholders Equity 159.8M
Debt to Equity 1.71

Cash Flow Metrics

Operating Cash Flow 5.7M
Free Cash Flow 11.7M

Revenue & Profitability Trend

Mesa Laboratories Income Statement From 2021 to 2025

Metric20252024202320222021
Revenue i241.0M216.2M219.1M184.3M133.9M
Cost of Goods Sold i90.1M82.9M85.4M75.2M46.9M
Gross Profit i150.9M133.2M133.7M109.1M87.0M
Gross Margin % i62.6%61.6%61.0%59.2%65.0%
Operating Expenses
Research & Development i19.5M19.3M20.5M15.8M10.4M
Selling, General & Administrative i115.0M111.5M109.9M88.6M64.3M
Other Operating Expenses i-----
Total Operating Expenses i134.5M130.8M130.4M104.4M74.7M
Operating Income i16.3M2.5M3.3M4.7M12.4M
Operating Margin % i6.8%1.1%1.5%2.6%9.2%
Non-Operating Items
Interest Income i----107.0K
Interest Expense i11.9M5.7M4.8M3.9M8.0M
Other Non-Operating Income1.5M-272.4M1.1M2.8M-2.0M
Pre-tax Income i6.0M-275.6M-389.0K3.6M2.3M
Income Tax i7.9M-21.4M-1.3M1.7M-971.0K
Effective Tax Rate % i133.1%0.0%0.0%47.6%-42.2%
Net Income i-2.0M-254.2M930.0K1.9M3.3M
Net Margin % i-0.8%-117.6%0.4%1.0%2.4%
Key Metrics
EBITDA i39.5M36.2M37.5M32.5M28.0M
EPS (Basic) i$-0.36$-47.20$0.17$0.36$0.66
EPS (Diluted) i$-0.36$-47.20$0.17$0.35$0.64
Basic Shares Outstanding i54210005386000532100052120004975000
Diluted Shares Outstanding i54210005386000532100052120004975000

Income Statement Trend

Mesa Laboratories Balance Sheet From 2021 to 2025

Metric20252024202320222021
Assets
Current Assets
Cash & Equivalents i27.3M28.2M32.9M49.3M263.9M
Short-term Investments i-----
Accounts Receivable i42.0M39.1M42.6M41.2M23.8M
Inventory i25.4M32.7M34.6M24.6M11.2M
Other Current Assets2.9M3.3M4.0M9.1M4.9M
Total Current Assets i102.7M109.4M119.0M124.3M303.7M
Non-Current Assets
Property, Plant & Equipment i29.9M24.9M18.9M18.9M13.2M
Goodwill i460.4M473.9M789.7M832.4M433.4M
Intangible Assets i96.9M113.8M216.8M250.1M111.7M
Long-term Investments-----
Other Non-Current Assets19.7M11.8M11.4M13.1M3.1M
Total Non-Current Assets i330.7M337.4M542.9M583.1M297.7M
Total Assets i433.3M446.8M661.8M707.4M601.5M
Liabilities
Current Liabilities
Accounts Payable i5.7M6.0M6.1M7.9M4.5M
Short-term Debt i104.6M3.0M2.9M2.8M1.0M
Current Portion of Long-term Debt-----
Other Current Liabilities-----
Total Current Liabilities i164.0M44.3M43.4M48.1M32.6M
Non-Current Liabilities
Long-term Debt i76.9M221.7M183.3M218.4M145.7M
Deferred Tax Liabilities i20.2M19.8M34.0M39.2M16.3M
Other Non-Current Liabilities12.5M15.6M7.7M7.9M715.0K
Total Non-Current Liabilities i109.6M257.1M225.0M265.5M162.7M
Total Liabilities i273.5M301.4M268.4M313.6M195.2M
Equity
Common Stock i358.5M343.6M332.1M313.5M317.7M
Retained Earnings i-188.9M-183.5M74.2M76.7M72.5M
Treasury Stock i-----
Other Equity-----
Total Shareholders Equity i159.8M145.4M393.5M393.8M406.2M
Key Metrics
Total Debt i181.5M224.7M186.1M221.1M146.7M
Working Capital i-61.3M65.0M75.6M76.3M271.2M

Balance Sheet Composition

Mesa Laboratories Cash Flow Statement From 2021 to 2025

Metric20252024202320222021
Operating Activities
Net Income i-2.0M-254.2M930.0K1.9M3.3M
Depreciation & Amortization i24.5M31.6M33.1M25.1M17.7M
Stock-Based Compensation i13.1M11.9M12.5M11.4M9.3M
Working Capital Changes i-3.1M7.0M-13.2M-3.8M2.7M
Operating Cash Flow i39.7M-229.4M31.9M42.6M34.5M
Investing Activities
Capital Expenditures i-4.2M-2.6M-4.5M-4.4M-2.0M
Acquisitions i0-78.7M-5.0M-300.8M0
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-4.2M-81.3M-9.5M-305.2M-2.0M
Financing Activities
Share Repurchases i-----
Dividends Paid i-3.5M-3.4M-3.4M-3.3M-3.2M
Debt Issuance i73.5M71.0M070.0M0
Debt Repayment i-115.8M-33.5M-36.0M-21.0M0
Financing Cash Flow i-47.2M32.5M-40.3M44.5M141.3M
Free Cash Flow i42.3M41.6M23.4M34.8M35.1M
Net Change in Cash i-11.7M-278.2M-18.0M-218.1M173.8M

Cash Flow Trend

Mesa Laboratories Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 546.59
Forward P/E 8.81
Price to Book 2.07
Price to Sales 1.47
PEG Ratio 14.35

Profitability Ratios

Profit Margin -0.26%
Operating Margin 5.15%
Return on Equity -0.38%
Return on Assets 2.04%

Financial Health

Current Ratio 0.66
Debt to Equity 107.21
Beta 0.82

Per Share Data

EPS (TTM) $-0.13
Book Value per Share $31.36
Revenue per Share $44.57

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
mlab356.2M546.592.07-0.38%-0.26%107.21
Garmin 45.7B29.345.6320.73%23.21%2.34
Keysight 28.9B53.135.099.98%10.38%48.75
Faro Technologies 849.8M-3.25-0.34%-0.26%35.44
Ituran Location and 687.5M12.103.2629.41%16.35%2.45
Vishay Precision 394.0M116.201.19-0.39%-0.43%16.62

Financial data is updated regularly. All figures are in the company's reporting currency.